Literature DB >> 15111843

Limb salvage after infrainguinal bypass graft failure.

Zachary K Baldwin1, Benjamin J Pearce, Michael A Curi, Tina R Desai, James F McKinsey, Hisham S Bassiouny, Daniel Katz, Bruce L Gewertz, Lewis B Schwartz.   

Abstract

OBJECTIVE: The purpose of this study was to examine the outcome of patients in whom an infrainguinal bypass graft failed.
METHODS: This was a retrospective analysis of consecutive patients undergoing infrainguinal bypass grafting in a single institution over 8 years.
RESULTS: Six hundred thirty-one infrainguinal bypass grafts were placed in 578 limbs in 503 patients during the study period. The indication for surgery was limb-threatening ischemia in 533 patients (85%); nonautologous conduits were used in 259 patients (41%), and 144 (23%) were repeat operations. After a mean follow-up of 28 +/- 1 months (median, 23 months; range, 0-99 months), 167 grafts (26%) had failed secondarily. The rate of limb salvage in patients with graft failure was poor, only 50% +/- 5% at 2 years after failure. The 2-year limb salvage rate depended on the initial indication for bypass grafting: 100% in patients with claudication (n = 16), 55% +/- 8% in patients with rest pain (n = 49), and 34% +/- 6% in patients with tissue loss (n = 73; P <.001). The prospect for limb salvage also depended on the duration that the graft remained patent. Early graft failure (<30 days; n = 25) carried a poor prognosis, with 2-year limb salvage of only 25% +/- 10%; limb salvage was 53% +/- 5% after intermediate graft failure (<2 years, n = 110) and 79% +/- 10% after late failure (>2 years, n = 15; P =.04). Multivariate analysis revealed shorter patency interval before failure (P =.006), use of warfarin sodium (Coumadin) postoperatively (P =.006), and infrapopliteal distal anastomosis (P =.01) as significant predictors for ultimate limb loss.
CONCLUSION: The overall prognosis for limb salvage in patients with failed infrainguinal bypass grafts is poor, particularly in patients with grafts placed because of tissue loss and those with early graft failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111843     DOI: 10.1016/j.jvs.2004.01.027

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

Review 1.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

2.  A Multicenter Predictive Score for Amputation-Free Survival for Patients Operated on with an Heparin-Bonded ePTFE Graft for Critical Limb Ischemia.

Authors:  Walter Dorigo; Gabriele Piffaretti; Raffaele Pulli; Patrizio Castelli; Carlo Pratesi
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 3.  Preventing and treating foot complications associated with diabetes mellitus.

Authors:  Frank L Bowling; S Tawqeer Rashid; Andrew J M Boulton
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

4.  Treatment of failing vein grafts in patients who underwent lower extremity arterial bypass.

Authors:  Keun-Myoung Park; Yang Jin Park; Shin-Seok Yang; Dong-Ik Kim; Young-Wook Kim
Journal:  J Korean Surg Soc       Date:  2012-10-29

Review 5.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

6.  Use of Biodegradable Temporising Matrix (BTM) in the reconstruction of diabetic foot wounds: A pilot study.

Authors:  Beatrice Kuang; Guilherme Pena; Prue Cowled; Robert Fitridge; John Greenwood; Marcus Wagstaff; Joseph Dawson
Journal:  Scars Burn Heal       Date:  2022-09-21

7.  Factors associated with infrainguinal bypass graft patency at 1-year; a retrospective analysis of a single centre experience.

Authors:  Pasha Normahani; Ismail Yusuf Anwar; Alona Courtney; Amish Acharya; Viknesh Sounderajah; Chira Mustafa; Usman Jaffer
Journal:  Perfusion       Date:  2021-02-26       Impact factor: 1.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.